8-64798532-A-G

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_004820.5(CYP7B1):​c.56T>C​(p.Leu19Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00708 in 1,499,110 control chromosomes in the GnomAD database, including 645 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.039 ( 376 hom., cov: 33)
Exomes 𝑓: 0.0035 ( 269 hom. )

Consequence

CYP7B1
NM_004820.5 missense

Scores

2
16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 0.0950
Variant links:
Genes affected
CYP7B1 (HGNC:2652): (cytochrome P450 family 7 subfamily B member 1) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This endoplasmic reticulum membrane protein catalyzes the first reaction in the cholesterol catabolic pathway of extrahepatic tissues, which converts cholesterol to bile acids. This enzyme likely plays a minor role in total bile acid synthesis, but may also be involved in the development of atherosclerosis, neurosteroid metabolism and sex hormone synthesis. Mutations in this gene have been associated with hereditary spastic paraplegia (SPG5 or HSP), an autosomal recessive disorder. [provided by RefSeq, Apr 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0017033815).
BP6
Variant 8-64798532-A-G is Benign according to our data. Variant chr8-64798532-A-G is described in ClinVar as [Benign]. Clinvar id is 193293.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-64798532-A-G is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.131 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CYP7B1NM_004820.5 linkc.56T>C p.Leu19Pro missense_variant Exon 1 of 6 ENST00000310193.4 NP_004811.1 O75881Q05C57
CYP7B1NM_001324112.2 linkc.56T>C p.Leu19Pro missense_variant Exon 1 of 7 NP_001311041.1 Q05C57
LOC105375879XR_928992.3 linkn.-249A>G upstream_gene_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CYP7B1ENST00000310193.4 linkc.56T>C p.Leu19Pro missense_variant Exon 1 of 6 1 NM_004820.5 ENSP00000310721.3 O75881

Frequencies

GnomAD3 genomes
AF:
0.0386
AC:
5872
AN:
152134
Hom.:
377
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.134
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0149
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000621
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.000529
Gnomad OTH
AF:
0.0263
GnomAD3 exomes
AF:
0.00302
AC:
289
AN:
95666
Hom.:
10
AF XY:
0.00230
AC XY:
124
AN XY:
53878
show subpopulations
Gnomad AFR exome
AF:
0.110
Gnomad AMR exome
AF:
0.00510
Gnomad ASJ exome
AF:
0.000145
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000745
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000613
Gnomad OTH exome
AF:
0.00413
GnomAD4 exome
AF:
0.00352
AC:
4739
AN:
1346868
Hom.:
269
Cov.:
32
AF XY:
0.00303
AC XY:
2011
AN XY:
664370
show subpopulations
Gnomad4 AFR exome
AF:
0.136
Gnomad4 AMR exome
AF:
0.00688
Gnomad4 ASJ exome
AF:
0.000167
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000410
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000284
Gnomad4 OTH exome
AF:
0.00828
GnomAD4 genome
AF:
0.0386
AC:
5877
AN:
152242
Hom.:
376
Cov.:
33
AF XY:
0.0372
AC XY:
2772
AN XY:
74436
show subpopulations
Gnomad4 AFR
AF:
0.134
Gnomad4 AMR
AF:
0.0149
Gnomad4 ASJ
AF:
0.000288
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000207
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000529
Gnomad4 OTH
AF:
0.0260
Alfa
AF:
0.0180
Hom.:
25
Bravo
AF:
0.0435
ESP6500AA
AF:
0.0376
AC:
104
ESP6500EA
AF:
0.000343
AC:
2
ExAC
AF:
0.00298
AC:
191
Asia WGS
AF:
0.00636
AC:
22
AN:
3472

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Jun 12, 2017
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Nov 14, 2014
Eurofins Ntd Llc (ga)
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not provided Benign:2
Jan 02, 2018
Athena Diagnostics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Spastic paraplegia Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Hereditary spastic paraplegia Benign:1
Nov 12, 2021
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Hereditary spastic paraplegia 5A Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.53
T
BayesDel_noAF
Benign
-0.42
CADD
Benign
8.4
DANN
Benign
0.89
DEOGEN2
Benign
0.23
T
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.025
N
LIST_S2
Benign
0.28
T
MetaRNN
Benign
0.0017
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.0
N
PrimateAI
Uncertain
0.53
T
PROVEAN
Benign
-0.65
N
REVEL
Benign
0.20
Sift
Uncertain
0.016
D
Sift4G
Benign
0.088
T
Polyphen
0.0010
B
Vest4
0.27
MVP
0.42
MPC
0.14
ClinPred
0.0069
T
GERP RS
-0.71
Varity_R
0.11
gMVP
0.84

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs72554624; hg19: chr8-65711089; API